Sulzer Inter-Op Hip Shell Loosening Detected In 129 Patients Following Recall

The financial impact of Sulzer Orthopedics' Inter-Op acetabular shell hip implant recall Dec. 5 "will be more than offset" by a $32 mil. one-time payment from a separate litigation settlement to its Sulzer Spine-Tech subsidiary, the firm predicts.

More from Archive

More from Medtech Insight